Tyrozol Tablets p/o 5mg No. 10×5: Effective Treatment for Hyperthyroidism
Description
Tyrozol tablets p/o 5mg No. 10×5 are round, biconvex, film-coated tablets of light yellow color with a notch for breaking on both sides. They contain the active ingredient thiamazole, a medication used to treat hyperthyroidism, a condition where the thyroid gland produces too much thyroid hormone.
Key Benefits
- Effective Treatment: Tyrozol effectively inhibits the production of thyroid hormones, helping to manage the symptoms of hyperthyroidism.
- Versatile Application: It is used for various forms of hyperthyroidism, including conservative treatment, preparation for surgery, and treatment before radioactive iodine therapy.
- Available in 5mg Dosage: The 5mg dosage allows for precise titration to individual patient needs.
Important Information
- Potential Side Effects: While generally safe and effective, Tyrozol can cause side effects, including agranulocytosis (low white blood cell count), allergic reactions, and hypothyroidism.
- Pregnancy and Lactation: Tyrozol can cross the placenta and enter breast milk. Consult your doctor about the risks and benefits of using this medication during pregnancy or breastfeeding.
- Dosage and Administration: The dosage and duration of treatment are determined by your doctor based on your individual needs.
- Drug Interactions: Inform your doctor about any other medications you are taking, as Tyrozol can interact with other drugs.
This information is not intended to be a substitute for professional medical advice. Always consult with your doctor before starting any new medication.
Buy Tyrozol tablets p/o 5mg No. 10×5 online or at your local pharmacy.
| INN | THIAMAZOL |
|---|---|
| The code | 9 288 |
| Barcode | 4 054 839 369 339 |
| Dosage | 5mg |
| Active substance | Thiamazole |
| Manufacturer | Merck KGaA, Germany |
| Indications Applications | Treatment of hyperthyroidism, including the following: conservative treatment of hyperthyroidism, especially if there is little or no goiter; preparation for surgery in all forms of hyperthyroidism; preparation for planned treatment with radioactive iodine, in particular in patients with severe forms of hyperthyroidism; intermittent therapy after radioactive iodine treatment. prophylactic treatment in patients with latent (latent) hyperthyroidism, autonomic adenomas, or with a history of hyperthyroidism, for whom iodine treatment is mandatory (for example, when examining using iodine-containing contrast media). |
| Contraindications | hypersensitivity to thiamazole, other derivatives of thionamide or to any of the excipients that make up the drug. agranulocytosis, granulocytopenia; cholestasis before treatment; previously noted bone marrow damage after treatment with thiamazole or carbimazole; combined therapy with thiamazole and thyroid hormones during pregnancy and lactation, children under 3 years of age With caution, large goiter with narrowing of the trachea |
| Side effects | Circulatory and lymphatic systems Uncommon: agranulocytosis was observed in 0.3% – 0.6% of cases. Symptoms may appear even weeks and months after the start of treatment and lead to the need to discontinue the drug; Very rare: generalized lymphadenopathy, thrombocytopenia, pancytopenia. Endocrine system Very rare: insulin autoimmune syndrome with hypoglycemia (with a pronounced decrease in blood glucose). Nervous system Rare: reversible change in taste; Very rare: neuritis, polyneuropathy. Gastrointestinal disorders Very rare: salivary gland enlargement, vomiting. Liver and biliary tract disorders Very rare: cholestatic jaundice and toxic hepatitis. Symptoms usually resolved after discontinuation of the drug. A differential diagnosis should be made between clinically silent symptoms of cholestasis during the treatment period and disorders caused by hyperthyroidism – such as increases in GGT (gamma-glutamyltransferase) and alkaline phosphatase or its isoenzyme, specific for bones. Disorders of the skin and subcutaneous tissues Very often: allergic skin reactions (itching, redness, rashes). They are usually mild and often resolve with continued therapy; Very rare: generalized skin rash, hair loss, lupus-like syndrome. Musculoskeletal and connective tissue disorders Common: Gradual development of arthrolgia after several months of treatment Complications of a general nature and reactions at the injection site Rare: fever, weakness, weight gain. |
| Use during pregnancy and lactation | Forbidden to use |
| Age category | 3+ |
| Application Gender | Any |
| Release Form | tablets |
| Main Active Substances | thiamazole |
| Composition Means | Film-coated tablets active substance – thiamazole excipients: colloidal silicon dioxide, sodium starch glycolate (type C), magnesium stearate, hypromellose 2910/15, talc, powdered cellulose, corn starch, lactose monohydrate composition of the film shell: iron oxide yellow ( E 172), dimethicone 100, macrogol 400, titanium dioxide (E 171), hypromellose 2910/15 |
| Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
Related products
